Literature DB >> 12467806

Early and long term outcome of the arterial switch operation for transposition of the great arteries: predictors and functional evaluation.

Edvin Prifti1, Adrian Crucean, Massimo Bonacchi, Massimo Bernabei, Bruno Murzi, Stefano Vincenzo Luisi, Vittorio Vanini.   

Abstract

OBJECTIVES: The aims of this report were to study the early and late outcome in terms of mortality, freedom from reoperation, predictors for late pulmonary stenosis (PAS) and insufficiency of the neo-aortic valve (AVI) in patients with transposition of the great arteries (TGA) undergoing arterial switch operation (ASO).
MATERIALS AND METHODS: Between January 1990 and December 2001, 134 patients with TGA underwent ASO. The patients were divided in Group I (n=88)-TGA with intact ventricular septum and Group II (n=46)-TGA with ventricular septal defect (VSD). The pulmonary artery was reconstructed employing the direct anastomosis technique (PT-I) in 21 (15.7%) patients, the double-patch technique (PT-II) in 41 (30.6%), single pantaloon patch (partial circumference) (PT-III) in 46 (34%) and single pantaloon patch (total circumference) (PT-IV) in 35 (26%) patients. The mean follow-up was 3.4+/-1.3 years.
RESULTS: The hospital mortality was 17 (12.7%) patients. The mortality in Group I was significantly lower than Group II (P=0.002). The overall actuarial survival at 1, 3 and 5 years follow-up resulted to be 98, 93, and 91.5%, resulting to be significantly higher in Group I (P=0.032). The multivariate analysis revealed the complex TGA (P=0.007), VSD (P=0.032), coronary anomalies (P=0.004), aortic coarctation or hypoplastic aortic arch (P=0.021), left ventricular outflow tract obstruction (LVOTO) or moderate PAS (P=0.041) as strong predictors for poor free-reoperation cumulative survival. A strong inverse correlation was found between the mean trans-pulmonary gradient at follow-up and the age at the operation (r=-0.41, P<0.0001). The univariate analysis revealed the PT-I technique (P=0.002), prior moderate PAS (P=0.0001), and age <1 month (P=0.018) as strong predictors for moderate-to-severe PAS. The neo-AVI incidence was significantly higher in Group II (P=0.011). Predictors for neo-AVI were male sex (P=0.003), preoperative neo-AV Z-score >1 (P<0.001), prior or concomitant operation for aortic coarctation or hypoplastic aortic arch (P=0.001), LV retraining (P=0.003).
CONCLUSION: ASO remains the procedure of choice for the treatment of various forms of TGA with acceptable early and later outcome in terms of overall survival and free reoperation. Strong predictors for poor overall free-reoperation survival are complex TGA, VSD, coronary anomalies, aortic coarctation and LVOTO or moderate PAS. The pulmonary artery reconstruction using a single 'pantaloon patch' seems to offer less residual stenosis. Patients with a VSD and a significant mismatch between the neo-aortic root and distal aorta are at a higher risk for developing postoperative neo-AVI.

Entities:  

Mesh:

Year:  2002        PMID: 12467806     DOI: 10.1016/s1010-7940(02)00613-9

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  20 in total

1.  Follow-up outcomes 10 years after arterial switch operation for transposition of the great arteries: comparison of cardiological health status and health-related quality of life to those of the a normal reference population.

Authors:  Wilfred B de Koning; Magdalena van Osch-Gevers; A Derk Jan Ten Harkel; Ron T van Domburg; Alma W Spijkerboer; Elisabeth M W J Utens; Ad J J C Bogers; Willem A Helbing
Journal:  Eur J Pediatr       Date:  2007-11-07       Impact factor: 3.183

2.  Watching the right ventricle in treated congenital heart disease.

Authors:  Thomas L Gentles
Journal:  Heart       Date:  2007-12       Impact factor: 5.994

Review 3.  Ventricular performance after surgery for a congenital heart defect as assessed using advanced echocardiography: from doppler flow to 3D echocardiography and speckle-tracking strain imaging.

Authors:  Liselotte M Klitsie; Arno A W Roest; Nico A Blom; Arend D J ten Harkel
Journal:  Pediatr Cardiol       Date:  2014-01       Impact factor: 1.655

Review 4.  The importance of early involvement of paediatric palliative care for patients with severe congenital heart disease.

Authors:  Sophie Bertaud; David F A Lloyd; Joanna Laddie; Reza Razavi
Journal:  Arch Dis Child       Date:  2016-04-21       Impact factor: 3.791

5.  Outcomes of Patients After Arterial Switch Operation: 18 Years of Experience in a Single Medium-Volume Center.

Authors:  Paulo H Manso; Fernando T V Amaral; Tarcísio J S Júnior; Mauro C Jurca; Jorge Haddad; Walter V A Vicente; Ricardo N Sgarbieri; Fabio Carmona
Journal:  Pediatr Cardiol       Date:  2015-06-03       Impact factor: 1.655

6.  Tissue Doppler imaging detects impaired biventricular performance shortly after congenital heart defect surgery.

Authors:  Liselotte M Klitsie; Mark G Hazekamp; Arno A W Roest; Annelies E Van der Hulst; Birthe J Gesink-van der Veer; Irene M Kuipers; Nico A Blom; Arend D J Ten Harkel
Journal:  Pediatr Cardiol       Date:  2012-09-22       Impact factor: 1.655

Review 7.  Pulmonic Valve Disease: Review of Pathology and Current Treatment Options.

Authors:  Mouhammad Fathallah; Richard A Krasuski
Journal:  Curr Cardiol Rep       Date:  2017-09-16       Impact factor: 2.931

8.  Congenital Heart Defects in Adults : A Field Guide for Cardiologists.

Authors:  Anitra Romfh; Francesca Romana Pluchinotta; Prashob Porayette; Anne Marie Valente; Stephen P Sanders
Journal:  J Clin Exp Cardiolog       Date:  2012-06-15

9.  Aortic Coarctation 28 Days after an Arterial Switch Operation in a Neonate.

Authors:  Fumiaki Shikata; Toru Okamura; Takashi Higaki; Masahiro Okura; Ai Kojima; Shunji Uchita; Hironori Izutani
Journal:  Tex Heart Inst J       Date:  2016-08-01

10.  Reconstruction of a new pulmonary artery in arterial switch operation.

Authors:  Bai-Ping Sun; Shu Fang; Ze-Wei Zhang; Fang-Xia Chen; Jian-Hua Li; Ru Lin; Qiang Shu; Jian-Gen Yu
Journal:  World J Pediatr       Date:  2014-03-25       Impact factor: 2.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.